The Drug That Could Break American Health Care
Aduhelm, the first new Alzheimer’s drug in 18 years, may not work. But states and Medicare might pay billions of dollars for it anyway.
Latest
Glasshouse Images / Getty; Adam Maida / The Atlantic
Aduhelm, the first new Alzheimer’s drug in 18 years, may not work. But states and Medicare might pay billions of dollars for it anyway.